Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries
Circulation: Cardiovascular Quality and Outcomes · 2025-04 · 18 (4)
DOI: 10.1161/circoutcomes.124.011636 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2025-04. Verfasst von Marta M Williams und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Care Policy, Harvard Medical School, Boston, MA (M.A.W., B.L.). Hauptthemen laut MEDLINE: Device Approval, Heart-Assist Devices, Reimbursement Mechanisms, Insurance, Health, Reimbursement. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: The authorization process and coverage/reimbursement mechanisms for medical devices play critical roles in device adoption and usage. However, international variation in these processes remains poorly characterized, especially with regard to data transparency and the effects of reimbursement on usage. METHODS: This study examined publicly available databases, governmental agency recommendations and policies, and press releases from the United States, Canada, the United Kingdom, and the Netherlands to compare the regulatory approval processes and coverage/reimbursement mechanisms for 2 novel cardiovascular devices introduced in the early and late 2000’s: the Watchman left atrial appendage occlusion device and the Impella percutaneous ventricular assist device. In addition to qualitative comparisons for each country, this study compared the date of the first regulatory review, time from submission to review completion, device approval date, agency approval requirements, number of review cycles, and necessity of postapproval studies as determined by the regulator, date of funding decision, final funding decision, and requirements for device reimbursement by relevant government payors. RESULTS: Authorization data were easily accessible for the United States and Canada but extremely limited for the United Kingdom and the Netherlands. Chronologically, authorization occurred ≈10 years earlier in Europe (United Kingdom and the Netherlands) than in North America (United States and Canada) for both devices. The United States was the only country where the principal public payor (Medicare) explicitly reimbursed both procedures. The United States was similarly notable for more rapid adoption and higher utilization of both devices than the other countries, with the Watchman implanted at 3.4 devices per 100 000 adults annually and Impella used in 7 to 8 procedures per 100 000 people annually. In contrast, uptake was far lower in Canada and Europe. CONCLUSIONS: This research provides insights into how differences among countries in authorization and reimbursement mechanisms may impact the adoption and usage of medical devices, and may inform future policies on these processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Care Policy, Harvard Medical School, Boston, MA (M.A.W., B.L.).
- Department of Internal Medicine, Baylor College of Medicine, Houston, TX (N.R.S.).
- Department of Health Care Policy and Management, Erasmus University Rotterdam, The Netherlands (C.A.U.-d.G., C.A.d.U.).
- Department of Cardiology and the Department of Intensive Care Medicine, Maasstad Hospital, Rotterdam, The Netherlands (C.A.d.U.).
- Department of Internal Medicine and the Department of Healthy Policy and Management and the Institution for Social and Policy Studies, Yale School of Medicine, New Haven, CT (J.S.R.).
- Institute of Health Informatics, University College London, United Kingdom (M.O.M., A.B.).
ORCID-Profile: Marta M Williams, Nathan R Smith, Carin A Uyl-de Groot, Corstiaan A den Uil, Joseph S Ross, Mohamed O Mohamed, Mamas A Mamas, Amitava Banerjee, Dennis T Ko, Bruce Landon, Peter Cram
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Williams, M. M., Smith, N. R., Uyl-de Groot, C. A., den Uil, C. A., Ross, J. S., Mohamed, M. O., Mamas, M. A., Banerjee, A., Ko, D. T., Landon, B., & Cram, P. (2025). Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries. Circulation: Cardiovascular Quality and Outcomes, 18(4). https://doi.org/10.1161/circoutcomes.124.011636
Vancouver
Williams MM, Smith NR, Uyl-de Groot CA, den Uil CA, Ross JS, Mohamed MO, et al. Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries. Circulation: Cardiovascular Quality and Outcomes. 2025;18(4). doi:10.1161/circoutcomes.124.011636
BibTeX
@article{Williams2025,
author = {Williams, Marta M and Smith, Nathan R and Uyl-de Groot, Carin A and den Uil, Corstiaan A and Ross, Joseph S and Mohamed, Mohamed O and Mamas, Mamas A and Banerjee, Amitava and Ko, Dennis T and Landon, Bruce and Cram, Peter},
title = {Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries},
journal = {Circulation: Cardiovascular Quality and Outcomes},
year = {2025},
volume = {18},
number = {4},
doi = {10.1161/circoutcomes.124.011636}
}
EUVIMED